Advertisement
  • Improving Glioblastoma Treatment

    Phase I clinical trial finds adding a radiosensitizer may improve radiation’s ability to kill this fast-growing brain cancer.

    by Thomas Celona

  • Quality of Life Across the Lifespan

    As more people diagnosed with and treated for cancer live years beyond treatment, researchers look for ways to improve quality of life.

    by Kevin McLaughlin

  • Results That Matter

    Cancer medications granted accelerated approval are often confirmed despite not demonstrating a benefit in overall survival or quality of life.

    by Eric Fitzsimmons

  • April 5: The Week in Cancer News

    More cancer patients are enrolling in clinical trials, and sentinel node biopsies alone may be adequate for some early-stage breast cancers.

    by Marci A. Landsmann

  • Genetic Testing for Women With Breast Cancer

    New recommendations clarify when women diagnosed with breast cancer should be offered genetic testing for inherited cancer risk.

    by Laura Gesualdi-Gilmore

  • March 29: The Week in Cancer News

    Survival rates have increased for older AML patients who receive stem cell transplants, and cervical cancer diagnoses rise among women living in low-income counties.

    by Kevin McLaughlin

  • TIL Therapy Amplifies the Immune System’s Attack on Melanoma

    The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.

    by Sandra Gordon

  • March 22: The Week in Cancer News

    First CAR T-cell therapy approval in chronic lymphocytic leukemia, and Environmental Protection Agency announces a complete ban on asbestos use in manufacturing.

    by Thomas Celona

  • Dealing With Immediate Medical Test Results

    Patients have been entitled to immediate access to medical records and test results for three years as a result of the Cures Act. It has changed how patients and doctors share information.

    by Taneia Surles

  • March 15: The Week in Cancer News

    Modified CAR T-cell therapy shows promise in glioblastoma, and an immunotherapy may soon be available as an injection.

    by Eric Fitzsimmons